4.7 Article

Phase II Trial of Trastuzumab in Combination With Cytotoxic Chemotherapy for Treatment of Metastatic Osteosarcoma With Human Epidermal Growth Factor Receptor 2 Overexpression: A Report From the Children's Oncology Group

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cardiac & Cardiovascular Systems

Anthracycline-Associated Cardiotoxicity in Survivors of Childhood Cancer

Barry H. Trachtenberg et al.

PEDIATRIC CARDIOLOGY (2011)

Review Cardiac & Cardiovascular Systems

The use of B-type natriuretic peptide in paediatric patients: a review of literature

Silvia Favilli et al.

JOURNAL OF CARDIOVASCULAR MEDICINE (2009)

Review Oncology

Trastuzumab as adjuvant systemic therapy for HER2-positive breast cancer

Gabriella Mariani et al.

NATURE CLINICAL PRACTICE ONCOLOGY (2009)

Article Oncology

Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial

Thomas M. Suter et al.

JOURNAL OF CLINICAL ONCOLOGY (2007)

Article Medicine, General & Internal

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

EH Romond et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Physiology

Theoretical and empirical derivation of cardiovascular allometric relationships in children

T Sluysmans et al.

JOURNAL OF APPLIED PHYSIOLOGY (2005)

Article Oncology

Overexpression of the HER-2 oncogene does not play a role in high-grade osteosarcomas

JK Anninga et al.

EUROPEAN JOURNAL OF CANCER (2004)

Article Medicine, General & Internal

The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia

SE Lipshultz et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

Article Medicine, General & Internal

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

DJ Slamon et al.

NEW ENGLAND JOURNAL OF MEDICINE (2001)